Introduction
The E1A oncogene is the first viral gene expressed during productive infection of cells with human adenoviruses (Ads). Group C Ad E1A encodes two major regulatory proteins of 243 and 289 amino-acid residues (E1A 243R and E1A 289R) synthesized from alternatively spliced RNA transcripts of 12S and 13S, respectively (reviewed by Shenk, 2001 ). E1A proteins encode multiple domains with diverse biochemical and biological functions including transcriptional activation, transcriptional repression, induction of cellular DNA synthesis, cell immortalization, cell transformation, as well as the inhibition of metastasis and cell differentiation (reviewed by Gallimore and Turnell, 2001; Shenk, 2001; Frisch and Mymryk, 2002; Berk, 2005; Chinnadurai, 2006) . E1A 289R differs from E1A 243R by conserved region 3 (CR3) (amino-acid residues 140-185), a 46 amino-acid domain unique to 289R. CR3 is essential and sufficient for transcriptional activation of early Ad genes (Lillie et al., 1987; Green et al., 1988) . The Ad E1A 243R oncoprotein encodes two conserved domains and a non-conserved N-terminus in exon 1, which are essential for cell immortalization and cell transformation and can induce S-phase DNA synthesis and cell cycle progression by two pathways. The first, the Rb-E2F pathway, involves E1A sequences within CR1 (residues 41-80) and CR2 (residues 121-139), which possess contact sites for Rb family proteins. The second, the N-terminal pathway, is a major focus of our laboratory and has been mapped within the E1A N-terminal 80 amino acids (E1A 1-80). E1A 1-80 consists of CR1 and non-conserved residues 1-40 and takes on added importance because the growth regulatory functions of E1A require sequences within this region.
The protein domains of E1A have evolved to interact with key cellular transcription regulators and promoters to control cell cycle progression, cell differentiation and chromatin remodeling. There is limited understanding of the molecular mechanisms and the precise roles of cellular regulatory factors in these processes. The systematic study of E1A functional activities continues to provide opportunities to explore important and complex questions in cell growth regulation, oncogenesis and virus regulatory control.
An interesting biochemical function encoded in the E1A N-terminus is the ability to transcriptionally repress cellular genes involved in cellular proliferation and cell differentiation. The E1A repression function involves interaction with two pivotal cellular proteinsthe TATA-binding protein (TBP) component of TFIID, which is important for transcription initiation and the multifunctional co-activator and histone acetyltransferase p300. Sequences within the E1A N-terminus have been reported to bind several other important cellular proteins, including PCAF, p400, hGCN5, TRRAP and Tip60, which are likely involved in chromatin remodeling and histone acetylation (reviewed by Frisch and Mymryk, 2002) .
A recombinant protein containing only the N-terminal 80 amino acids strongly represses transcription of E1A-repressible promoters in a manner that recapitulates the repression activity of the full-length E1A 243R protein in vitro and in vivo (Song et al., 1995a (Song et al., -c, 1997 Boyd et al., 2002; Loewenstein et al., 2006) . A detailed mutational/functional analysis has identified two regions or sub-domains that are critical for E1A repression: amino acids approximately 1-30 and approximately 48-60. Key amino acids in the first sub-domain include (i) residues 2-6 with 6Cys being especially important, and (ii) residue 20Leu. All of these residues are essential for the transcription-repression function and for disruption of a TBP-TATA complex, but only amino-acid residue 6 appears to be critical for binding p300 under in vitro conditions (Boyd et al., 2002) . Of interest, the E1A N-terminus can interact with the DNA methyltransferase, Dnmt1, and this reaction is abolished by a point mutation at Leu 20 of E1A (Burgers et al., 2007) , which is critical for E1A transcription repression (Boyd et al., 2002) . In contrast, amino acids 53Ala, 54Pro, 55Glu and 56Asp within the second sub-domain are important for the E1A repression function and for binding of E1A's cellular partner p300, but not for binding TBP or for disruption of a TBP-TATA complex (Loewenstein et al., 2006) . These combined findings suggest a two-step model as a molecular mechanism for E1A repression (Figure 1) . Briefly, E1A gains access to repressible promoters by interaction with cellular partners such as p300 as molecular scaffolds and, thereby, gains access to TBP where it disrupts the basal transcription machinery. Consistent with this model, TBP is recruited to a p300-E1A 1-80 complex as shown by an in vitro assembly assay (Loewenstein et al., 2006) . To further explore the first step of this model, we have carried out studies using model promoters containing tethered p300 and promoters containing tethered transcription activators that either recruit or do not recruit p300. The results of these transcription-repression experiments support a direct role for p300 in the E1A repression function consistent with the proposed model.
Results
Transcription repression by E1A 243R in vivo is promoter-specific and targets the basal transcription machinery Several lines of evidence show that E1A repression targets the TBP component of the basal transcription machinery (Song et al., 1995a (Song et al., , 1997 Boyd et al., 2002) : (i) TFIID or recombinant TBP reverses transcription repression by E1A in vitro; (ii) TBP restores the ability of an E1A 1-80 affinity-depleted nuclear extract to support transcription and (iii) TBP-TATA interaction in vitro is disrupted by E1A 243R or E1A 1-80. If E1A targets the basal transcription machinery, why aren't all E1A transcription repression targets promoter-bound p300 M Green et al promoters repressed by E1A? As shown in Figure 2 , transcription from the reporter plasmid pBenn-CAT (the CAT gene driven by the upstream 533 nt of HIV LTR) is efficiently repressed by expression of E1A 243R in transient expression experiments. In contrast, transcription from the reporter plasmid pMLP-CAT (the CAT gene driven by the upstream 262 nt of MLP) is not repressed under the same conditions (and in fact is to an extent activated). Either the MLP contains an element(s) that protects it from repression by E1A or the HIV LTR contains an element(s) that facilitates interaction with E1A. With regard to the E1A repression model (Figure 1) , it is noted that HIV LTR can interact with p300 via NF-kB (Parker et al., 1997) , whereas MLP is not known to interact with p300 but instead interacts with USF transcription factors (Carthew et al., 1985; Sawadogo and Roeder, 1985) .
A minimal core promoter activated by tethering p300 is repressible by E1A at the promoter level The Ad E1B minimal core promoter, fused to DNA-binding sites for the yeast Gal4 DNA-binding protein and the bacterial Lex A DNA-binding protein (2Lex2Gal-E1BTATA-CAT), was co-transfected with the vector Gal4-p300 (1737-2414) (Yuan et al., 1996) . Gal4-p300 (1737-2414) expresses the Gal4 DNA-binding domain fused to p300 residues containing a transcription-activation region and the E1A-binding site on p300 (residues 1763-1811). Basal activity from the core promoter is negligible, but is strongly activated by expression of Gal4-p300 (1737-2414) (Figure 3) . Significantly, coexpression of E1A 243R efficiently represses Gal4-p300-activated transcription by greater than 90% (Figure 3 ). For comparison, the well-studied repressor ZEB as a fusion protein with LexA (L-RD-ZEB) also efficiently represses p300-activated transcription (Figure 3) . ZEB represses by a mechanism that appears to be different from that of E1A (Postigo and Dean, 1999a) .
These data does not distinguish between two possibilities: (i) E1A represses the activated promoter by interacting with Gal4-p300 at the promoter, or (ii) E1A sequesters intracellular Gal4-p300, thereby squelching activation of the promoter. To address this issue, the same construct fused to a Luc reporter (2Lex2Gal-E1BTATA-Luc) was co-transfected with fixed amounts of E1A 243R (50 or 100 ng) and escalating amounts of Gal4-p300 (1737-2414). If E1A were to repress by sequestering p300, one would expect that some level of Gal4-p300 would overcome, at least in part, repression by E1A. As shown, when either 100 ng of E1A 243R (Figure 4a ) or 50 ng ( Figure 4b ) was transfected, no amount of co-transfected Gal4-p300 was found to overcome E1A repression; the p300-activated promoter was repressed over 90% in all cases by E1A 243R. Table 1 summarizes four experiments that cover from 1-to 200-fold molar ratios of Gal4-p300 (1737-2414) to E1A 243R DNAs. As seen in Table 1 , Gal4-p300 (1737-2414) at 50, 100 and 200 ng exhibits a linear dose response, that is, a doubling of promoter activation occurs with each doubling of Gal4-p300 concentration. E1A 243R DNA at 2 ng is below saturating levels as it represses only at approximately 60 % at molar ratios of 50-200 of Gal4-p300 (1737-2414) to E1A 243R. E1A 243R DNA at 5-100 ng efficiently represses transcription up to 98% at high ratios of p300 to E1A under conditions where Gal4-p300 (1737-2414) nearly saturates the promoter (200-800 ng) as determined by luciferase assay. The data in Figure 4c demonstrate that Gal4-p300 (1737-2414) and E1A 243R are efficiently expressed in transfection experiments. Antibodies against Gal4 and E1A detects the expression of transfected Gal4-p300 (1737-2414) and E1A 243R in a dose-dependent manner at levels where E1A efficiently represses the p300-activated basal promoter. Thus, these combined results show that Gal4-p300 (1737-2414) is expressed in a dose-dependent manner both in terms of promoter activation and protein levels expressed.
Finally, to demonstrate that E1A does repress by interaction with p300 on the promoter and not merely by sequestering transfected Gal4-p300, transient chromatin immunoprecipitation (ChIP) analysis (Lavrrar and Farnham, 2004) was performed with antibodies specific for Gal4 and for E1A on the 5Gal-E1BTATA-Luc core promoter activated by Gal4-p300 (1737-2414) and repressed by E1A 243R. Real-time PCR analysis was carried out using primers specific for the E1B promoter. As shown in Figure 4d , Gal4 protein is greatly enriched on the core E1B promoter as expected. Importantly, E1A protein is also substantially enriched on the promoter, indicating that Figure 3 Activated transcription from a core promoter by tethering p300 is strongly repressed by coexpression of E1A 243R. The core promoter-reporter 2Lex2Gal-E1BTATA-CAT (300 ng) was transfected with Gal4-p300 (1737-2414; 500 ng) with and without pcDNA3-E1A 243R (250 ng) or L-RD-ZEB (250 ng) and analysed as described in the legend to Figure 2 . The p300-activated core promoter is efficiently repressed by E1A 243R or L-RD-ZEB. A schematic illustrating the interpretation of these results is shown.
E1A transcription repression targets promoter-bound p300 M Green et al under these conditions of transcription repression, E1A interacts with the promoter containing p300. E1A 243R is not enriched on the promoter in the absence of co-transfected Gal4-p300 (1737-2414) (data not shown).
The minimal core promoter activated by transcription factors that can recruit p300 is repressible by E1A Under natural conditions, endogenous p300 is recruited to a promoter by interaction with promoter-bound DNA-binding transcription factors. A number of transcription factors have been reported to possess binding sites on p300, many of which have been mapped on the 2414 amino acid p300 molecule (reviewed by Chan and La Thangue, 2001 ). To more accurately depict the physiological state, 2Lex2Gal-E1BTATA-CAT was activated by transfection with activation domains of several transcription factors fused to either Gal4 or LexA DNA-binding domains, and analysed for ability to be repressed by co-transfected E1A 243R. NF-kB proteins are involved in inflammatory reactions, signal pathways and development. The transcription factor p65 member of this family binds p300 at the KIX domain, which is distant from the CH3 domain that binds E1A . As shown in Figure 5a , Gal4-p65 greatly activates the core promoter. When E1A 243R is coexpressed from pcDNA3-E1A 243R, transcription is repressed to essentially Figure 4 (a-d) Increasing amounts of Gal4-p300 are unable to decrease repression by E1A 243R. C33a cells in 24-well plates were transfected, using a 3 to 1 ratio of jetPEI (Polyplus) to DNA, with 100 ng amounts of 2Lex2Gal-E1BTATA-Luc and escalating amounts of Gal4-p300 (1737-2414) and challenged with either 100 ng (a) or 50 ng (b) of pcDNA3-E1A 243R. Gal4-p300 (1737-2414) was unable to decrease transcription repression by E1A. Analysis was performed by luciferase assay. (c) Protein expression levels of E1A 243R and Gal4-p300 (1747-2414) in co-transfected cells. Shown in the first panel are immunoblot analysis of the protein expressed from 20 and 100 ng of Gal4-p300 (1737-2414). The relative amounts of protein expressed as measured by quantitative immunoblot analysis is indicated (Materials and methods). At these levels, there is a clear dose response with increasing amounts of Gal4-p300 (1737-2414). The second panel shows analysis of protein expressed from 5 and 20 ng of E1A 243R expression plasmid and the degree of transcription repression (luciferase). Also shown is the relative amounts of E1A 243R expressed as determined by immunoblot analysis. (d) Chromatin immunoprecipitation (ChIP) analysis indicates that E1A directly associates with an E1A 243R repressed promoter. Transient ChIP analysis was performed using 10 cm 2 cultures of C33a cells transfected with 5Gal-E1BTATA-Luc (1 mg), activated by Gal4-p300 (3 mg), and repressed by E1A 243R (2 mg) (see schematic). Real-time PCR analysis demonstrates that p300 (Gal4) and E1A occupy the promoter. Shown is a plot of fluorescence versus PCR cycle number generated by the Opticon 2 monitor software. In parentheses are given the average Ct value (the cycle number at which fluorescence crosses the threshold value) of triplicate samples of input chromatin, chromatin precipitated by Gal4 antibody, chromatin precipitated by E1A antibody and background (no antibody (No-Ab) control). A difference of one Ct between an antibody specific immunoprecipitate and the No-Ab control represents about a twofold enrichment of the 5Gal-E1BTATA-luc reporter in the sample.
E1A transcription repression targets promoter-bound p300 M Green et al background levels. Coexpression with the empty plasmid pcDNA3 does not have any significant effect on Gal4-p65 activation. As expected, the repressor L-RD-ZEB also represses transcription from the activated core promoter.
This result was extended to other transcription factors reported to interact with p300. E1A can repress the expression of muscle-specific genes and block differentiation of muscle cells (Webster et al., 1988) in a process regulated by the MyoD family of transactivators, which include the helix-loop-helix protein MyoD. MyoD binds to the same general region of p300 as does E1A (Yuan et al., 1996) . As shown in Figure 5b , Gal4-MyoD greatly activates the promoter, and coexpression of E1A 243R dramatically represses transcription from the activated promoter.
The transcription factor cMyb functions as an oncogene when transduced into retrovirus genomes. Like p65, cMyb binds to the KIX domain of p300. As shown in Figure 5c , co-transfection of Gal4-cMyb with 2Lex2Gal-E1BTATA-CAT strongly activates the promoter. Just as with the promoter activated by MyoD and by p65, the cMyb-activated promoter is efficiently repressed by coexpression of E1A 243R.
TFE3 is a basic helix-loop-helix transcription factor, which is a part of the MiT transcription factor family that is involved, among other things, in the regulation of osteoclast development and renal cell carcinoma. Phosphorylation of TFE3 has been reported to trigger recruitment of p300 in cultured osteoclasts (Weilbaecher et al., 2001) . As shown in Figure 5d , the fusion protein Gal4-TFE3 (Postigo and Dean, 1999a) greatly activates expression from the core promoter and activated transcription is strongly repressed by E1A 243R. Thus, activation by several transcription factors reported to recruit p300 is efficiently repressed by E1A 243R. These results are consistent with the transcriptionrepression model that E1A can access promoters through interaction with p300.
The minimal core promoter activated by transcription factors that do not interact with p300 is resistant to E1A repression It is important to examine transcription factors that are not known to recruit p300 to the promoter. USF was initially identified as a transcription factor for the MLP promoter (Carthew et al., 1985; Sawadogo and Roeder, 1985) . The USF transcription factors are basic helixloop-helix proteins. USF1 and USF2 form dimers that recognize specific E-box elements with a similar consensus sequence to that of cMyc. USF has been reported to antagonize the ability of cMyc and E1A to stimulate cell division (Luo and Sawadogo, 1996) . As demonstrated in Figure 5e , both Gal4-USF1 and Gal4-USF2 activate transcription from 2Lex2Gal-E1BTATA. However, in both cases, coexpression of E1A 243R has no significant repression activity on the activated promoter. By contrast, the repressor L-RD-ZEB, which represses transcription by a mechanism different from that of E1A, is able to repress transcription from the promoter activated by either USF1 or USF2, demonstrating that USF-activated transcription can be repressed by a different mechanism. The inability of E1A to repress USF-activated transcription is consistent with the inability of E1A 243R to repress the native MLP promoter that can interact with USF but not p300.
Tethering p300 to the non-repressible promoter MLP converts it to an E1A-repressible promoter The results described above support the conclusion that the E1A repression domain can use promoter-bound p300 to facilitate access to the promoter. This suggests that one feature of an E1A repressible promoter is the presence of p300 or another co-activator on the promoter that E1A can access. This is turn suggests that the resistance of a non-repressible promoter to E1A may be due, in part, to the lack of a suitable promoterbound co-activator. To test this hypothesis directly, we co-transfected Gal4-p300 (1737-2414) with a reporter plasmid containing the MLP promoter fused to the CAT gene and five Gal4 DNA-binding sites (5Gal-MLP-CAT), followed by expression of E1A 243R from an Ad vector. Transcription from the MLP is greatly enhanced by Gal4-p300 (1737-2414) (Figure 6a ). Significantly, MLP-enhanced transcription is substantially repressed by E1A (Figure 6a) . Thus, promoter-tethered p300 can serve not only to activate transcription from the MLP but also to facilitate access of E1A 243R to the promoter.
Chromatin immunoprecipitation analysis was performed with antibody against E1A to demonstrate that repression involves occupancy of the promoter by E1A. Real-time PCR analysis using primers specific for Tabulation of four independent experiments representing the averages of multiple transfections. Transfections were performed in 24-well plates with the indicated amount of plasmid DNA per well, 100 ng of the 2Lex2Gal-E1BTATA-Luc reporter and a 3:1 ratio of jetPEI to DNA. The percentage repression was measured by luciferase assay.
E1A transcription repression targets promoter-bound p300 M Green et al the MLP shows that the repressed MLP promoter is highly enriched for E1A compared to the no-antibody control (Figure 6b ). Experiments using antibodies against Gal4 and p300 show that Gal4-p300 (1737-2414) occupies the 5Gal-MLP-Luc promoter to approximately the same extent as E1A (data not shown). These findings are consistent with the proposed model that E1A accesses the promoter by interaction with a suitable promoter-bound co-activator such as p300. (d) 2Lex2Gal-E1BTATA-CAT (750 ng), Gal4-TFE3 (320 ng) and the indicated amounts of pcDNA3-E1A 243R. (e) 2Lex2Gal-E1BTATA-CAT (750 ng), Gal4-USF1 (500 ng) or Gal4-USF2 (500 ng), pcDNA3-E1A 243R (500 ng) and L-RD-ZEB (500 ng). In all four cases of transcription factors that recruit p300 (a-d) activated transcription is efficiently repressed by E1A 243R, whereas in the two cases of transcription factors not known to use p300 activated transcription is resistant to repression by E1A 243R but is susceptible to repression by L-RD-ZEB (e).
E1A transcription repression targets promoter-bound p300 M Green et al Discussion p300 was originally discovered through its association with E1A in co-immunoprecipitation experiments (reviewed by Moran, 1993) . The generalization has been formulated that E1A transcription repression is caused by sequestration of intracellular p300. However, this explanation is far from clear (reviewed in Goodman and Smolik, 2000; Gallimore and Turnell, 2001 ). We do not exclude the possibility that p300 can interact with E1A off the promoter, but suggest that such an interaction may not be relevant to the mechanism of E1A repression under physiological conditions. Interaction of p300 with E1A off the promoter could represent an artifact of overexpression of p300. In this regard, Eckner et al., 1994 , who first cloned and functionally analysed p300, reported the presence of p300-specific speckles in transfected cell nuclei , representing aggregates presumably due to p300 overexpression and its high cysteine content. Transient expression of p300 with E1A only marginally overcame E1A repression of the SV40 enhancer and only at very low levels of E1A. p300 mutants with deletion in the E1A-binding site overcame (about 50%) repression of the SV40 enhancer (Eckner et al., 1994) . It was suggested that endogenous p300 was sequestered by transfected E1A and, thus, the exogenous p300 mutants could then activate the SV40 enhancer. However, the observation that p300 mutants defective in binding E1A were more effective in overcoming E1A repression can be interpreted to support our proposed model-p300 mutants lacking the ability to bind E1A when bound to the promoter can activate, but no longer serve as a scaffold that E1A must use to access the promoter and repress transcription. In several other reports, overexpression of CMV-p300 was found to overcome E1A repression of different promoters to various degrees. In these studies, the role of p300 as an activator for specific promoters was the main focus and not the interaction of E1A with p300 (for example, Yuan et al., 1996; Parker et al., 1997) . The experiments described in Figures 4a-c and Table 1 are based on a different experimental approach. By use of the basal promoter-reporter 2Lex2Gal-E1BTATA-Luc, complications due to endogenous p300 are avoided. Expression of Gal4-p300 (1737-2414) delivers the p300 E1A-binding site/activation domain directly to the promoter-reporter where the effects of E1A are measured. The highly transfectable C33a cell line in combination with the efficient jetPEI transfection reagent allows the use of low levels of E1A 243R vector (for example, 2 ng) and truncated p300 vector (for example, 50 ng), minimizing p300-E1A aggregate formation. Previous reports in which E1A repression was reduced by p300 generally used much higher quantities of both E1A and full-length p300 vectors (4-10 mg) where aggregate formation might compromise the interpretation of the results. As discussed below, our combined studies suggest a more direct and active role for p300 in E1A transcription repression.
Single amino-acid substitution analysis of E1A repression sub-domains showed a strong correlation Figure 6 (a) Tethering p300 to the non-repressible major late promoter (MLP) converts it to an E1A repressible promoter. C33a cells were transfected and analysed, as described in the legend to Figure 2 , with 5Gal-MLP-CAT (300 ng), Gal4-p300 (1737-2414) (500 ng) and pcDNA3-E1A 243R (1000 ng). MLP is activated by Gal4-p300 (1737 Gal4-p300 ( -2414 and repressed by E1A 243R. (b) Chromatin immunoprecipitation (ChIP) analysis shows that E1A 243R occupies the repressed MLP. Transient ChIP analysis was performed on 10 cm 2 cultures of C33a cells transfected with 5Gal-MLP-Luc (1 mg), pcDNA3 (2 mg), Gal4-p300 (1737-2414) (3 mg) and infected with 200 multiplicity of infection of an adenovirus vector expressing E1A 243R (Ad/CMV-E1A 243R (Green et al., 2008) at 6 h after transfection. Shown is a plot of fluorescence versus cycle number for triplicate samples analysed by real-time PCR. The average Ct values of the input chromatin, chromatin precipitated by E1A antibody and background (No-Ab) are given in parenthesis and demonstrate that E1A is highly enriched on the promoter. The insert shows a linear plot of log concentration versus Ct (generated by the Opticon 2 software) of triplicate quantification standards, 0.5 and 5 pg of the reporter plasmid 5Gal-MLP-Luc.
E1A transcription repression targets promoter-bound p300 M Green et al between sequences required for binding p300 and those essential for E1A transcription repression (Boyd et al., 2002; Loewenstein et al., 2006) and for cell transformation (Rasti et al., 2005) . These observations, coupled with studies that implicate the basal transcription machinery (the TBP component of TFIID) as a functional target of E1A repression (Song et al., 1995a (Song et al., , 1997 Boyd et al., 2002) , suggest a two-step model of E1A repression: (i) E1A accesses a specific promoter by interaction with a DNA-bound transcription co-activator (such as p300) and (ii) E1A disrupts TBP-TATA interaction at that promoter (Figure 1) . Consistent with this model, promoters activated by p300-interacting transcription factors are strongly repressed by E1A 243R (Figures 5a-d) , whereas activators not known to interact with p300 are resistant to E1A repression (Figure 5e ). These experiments used the E1B core promoter, which has negligible basal activity unless activated by a transcription factor tethered to the promoter. Thus, the interaction of E1A with specific transcription activators via their interacting co-activator, that is p300, can be examined. The results indicate that the E1B core promoter containing bound p300 can be strongly repressed by E1A 243R. The conclusion that E1A repression involves interaction with promoter-bound p300 rather than intracellular p300 (sequestration or squelching) is supported by two lines of evidence. First, dose-response measurements show that increasing amounts of p300 do not significantly decrease E1A repression (Figures 4a and b) . Second, ChIP analysis demonstrates that E1A 243R is present on the E1A repressed promoter (Figure 4d) .
Studies with MLP provide additional support for the proposed model. MLP, which is not repressed by E1A under natural conditions, can be converted to an E1A-repressible promoter by tethering p300 (Figure 6a) . The conversion from a non-repressible to a repressible promoter requires the occupancy of the promoter by E1A, as shown by ChIP analysis (Figure 6b ). This compelling observation indicates that promoter-bound p300 can be targeted by the E1A repression domain to transcriptionally repress transcription from the promoter.
Several caveats are noted. First, the fact that a promoter does not use p300 does not necessarily mean that it may not be repressible by E1A. E1A could target other E1A N-terminus-interacting co-activators, for example, CBP, p400, TRRAP, GCN5 and Tip60. Second, the fact that a promoter uses p300 does not necessarily mean that it will be repressible by E1A. The critical issues may be (i) whether E1A can bind to the specific promoter via interaction with a co-activator, and (ii) whether p300-bound E1A can subsequently interact with TBP. Promoters that do not facilitate these two interactions would not be repressed. Different promoters contain numerous interacting regulators, including for example, upstream enhancers, activators, repressors and TAFs (reviewed by Taatjes et al., 2004) whose combinatorial interactions could sterically block interaction of E1A with a promoter-bound co-activator or co-activator-bound E1A with the TBP-TATA complex. Further studies are needed to understand, in molecular detail, the mechanism by which E1A accesses and represses the complex endogenous promoters involved in growth regulation.
Materials and methods

Plasmids
The construction of pcDNA3-E1A 243R is described in Boyd et al., 2002 and Gal4-p300 (1737 -2414 in Yuan et al., 1996. Promoter-reporter plasmids 2Lex2Gal-E1BTATA-Luc and 5Gal-E1BTATA-luc are described in Dorris and Struhl, 2000 ; 5Gal-MLP-Luc, 2Lex2Gal-E1BTATA-CAT and 5Gal-MLP-CAT in Weintraub et al., 1995 and Dean, 1999b . pBenn-CAT was provided by the NIAIDS repository. Gal4-activator plasmids were obtained from several sources. Gal4-NF-kB-p65; Gal4-MyoD (amino acid 1-318); Gal4-cMyb; Gal4-TFE3 (amino acid 2-216) and LexA-RD-ZEB are described in Weintraub et al., 1995 and Dean, 1999b ; Gal4-USF1 and Gal4-USF2 in Qyang et al., 1999 . All plasmids used in transfection studies were purified by double CsCl density gradient centrifugation to facilitate reproducible transfection.
Cell culture and transfection C33a cells were obtained from the American Type Culture Collection and maintained in Dulbecco's modified Eagle's medium and 10% fetal bovine serum. Cells were transfected as described in the figure legends with either Fugene (Roche, Indianapolis, IN, USA) or jetPEI (Bridge Bioscience Corp., Portsmouth, NH, USA) using the manufacturer's guidelines. The DNA content of transfection experiments was equalized by addition of the empty vector pcDNA3. Co-transfected plasmids expressing RSV-bGal (CAT assay) or Renilla luciferase (luciferase assay) were used to normalize transfection results. Transfections were repeated at least twice.
Quantitation of promoter activity
Depending upon the reporter, expression was measured either by CAT assay or luciferase assay. CAT assay was performed essentially as described by Gorman et al., 1982 . Quantitation of CAT activity was determined by Phosphorimage analysis of thin layer plates on a Storm 840 Phosphorimager (GE Healthcare, Piscataway, NJ, USA). Luciferase assay was performed with the Dual-Luciferase assay system (Promega, Madison, WI, USA) and quantitated using a Turner Design luminometer .
Immunoblot analysis
Western blot analysis was performed using primary antibody against Gal4 (Santa Cruz, Santa Cruz, CA, USA, SC-577) to detect expression of Gal4-p300 (1737-2414) or against E1A (Santa Cruz SC-430) to detect expression of E1A 243R. Blots were treated with secondary antibody labeled with horse radish peroxidase (Pierce Biotechnology, Rockford, IL, USA) and developed using Supersignal ECL chemistry (Pierce Biotechnology). After exposure to X-ray film, signals on blots were quantitated on a Typhoon Trio (GE Healthcare) using ImageQuant TL software.
ChIP assay and real-time PCR analysis C33a cells growing in 10 cm 2 dishes were transfected as described in the figure legends, cross-linked with formaldehyde and chromatin isolated and immunoprecipitated essentially as E1A transcription repression targets promoter-bound p300 M Green et al described in Takahashi et al. (2000) (B Dynlacht, personal communication) . To determine whether E1A 243R was present on the promoter, monoclonal antibody against E1A (BD Biosciences, San Jose, CA, USA, 554155) was used. To detect Gal4-p300 (1737-2414) on the promoter, polyclonal antibodies against Gal4 (Santa Cruz SC-577X) and p300 (Santa Cruz SC-585X) were used. No-antibody controls were used in all transient transfection ChIP experiments. Isotype-specific antibody controls (HA polyclonal, SC-805 or His-6 monoclonal, SC-8036) were used in many of the transient transfection ChIP experiments and gave essentially the same values as no-antibody controls. The final purified immunoprecipitated DNA in 100 ml was used for real-time PCR analysis in 96-well plates with the Opticon 2 real-time detection system (Bio-Rad, Hercules, CA, USA). Briefly, to triplicate 5 ml aliquots of chromatin DNA samples were added 5 ml of 2.5 mM primer pair specific for the promoter-reporter plasmids 2Gal2Lex-E1BTATA-Luc or 5Gal-MLP-Luc, and 10 ml of a 2X SYBR Green Quantitative RT-PCR (reverse transcription-PCR) reagent (Sigma, St Louis, MO, USA). Forty cycles of PCR were performed using a cycling protocol recommended by Sigma with optimization of annealing temperature for each primer pair.
